{"id":2310,"date":"2017-11-29T21:32:28","date_gmt":"2017-11-29T21:32:28","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=33054"},"modified":"2017-11-29T21:32:28","modified_gmt":"2017-11-29T21:32:28","slug":"mjnas-3q-financial-results-featured-various-media-outlets","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/11\/29\/mjnas-3q-financial-results-featured-various-media-outlets\/","title":{"rendered":"MJNA’s 3Q Financial Results Featured in Various Media Outlets"},"content":{"rendered":"

The announcement of MJNA\u2019s record-breaking Q3 revenue numbers were covered by at least eight investment and financial media outlets.<\/span><\/i><\/p>\n

Several media outlets ran articles spotlighting Medical Marijuana, Inc.\u2019s financial results for the third quarter ending September 30, 2017.<\/span><\/p>\n

MJNA released its Q3 financial numbers earlier this month, revealing a 255% quarter-over-quarter increase in gross revenue. The Company\u2019s gross revenue surged from $2,188,671 in Q3 2016 to $7,783,297 in Q3 2017.<\/span><\/p>\n

Additionally, MJNA reported a total gross profit increase from $1,266,488 in Q3 2016 to $5,034,464 in Q3 2017, a 297% quarter-over-quarter jump. The company also saw a year-over-year increase in year-to-date gross revenue, from $5,450,080 in 2016 to $17,098,785 in 2017.<\/span><\/p>\n

\"\"\"\"<\/p>\n

National financial and investing outlets covered the release of MJNA\u2019s financial results. In<\/span> CFN Media Group<\/span><\/i><\/a>\u2019s coverage of the announcement, the leading cannabis media network referred to MJNA as \u201ca compelling opportunity in the cannabis space.\u201d After citing the company\u2019s strong growth during the third quarter, <\/span>CFN Media Group<\/span><\/i> touted MJNA\u2019s \u201cdiversified operations across many geographies and subsets of the cannabis industry.\u201d<\/span><\/p>\n

The <\/span>CFN Media Group<\/span><\/i> article also highlighted the achievements of MJNA\u2019s investment portfolio, spotlighting the company\u2019s total equity of $334,136,047 as of last quarter. <\/span><\/p>\n

The piece showcased the announcement of MJNA investment company<\/span> AXIM<\/span>\u00ae<\/span> Biotechnologies<\/span><\/a> clinical study agreement with the University of British Columbia with its CanChew Plus<\/span>\u00ae<\/span> CBD chewing gum<\/span> for drug-induced psychosis in adults<\/span><\/a>. It also noted MJNA investment company<\/span> Kannalife\u2122 Sciences<\/span><\/a>\u2019s presentation of scientific data from its clinical trials at this year\u2019s<\/span> Annual ICRS Symposium on the Cannabinoids<\/span><\/a>.<\/span><\/p>\n

In conclusion, the media outlet suggested MJNA is a \u201cunique opportunity,\u201d as the North American cannabidiol (<\/span>CBD<\/span><\/a>) market expected to surpass $1 billion by 2020.<\/span><\/p>\n

Further Media Coverage<\/b><\/p>\n

Coverage of MJNA\u2019s Q3 financial results can also be found at the following media sources:<\/span><\/p>\n